AAHRPP Accredits First Organization in China
The
- Beijing YouAn Hospital, Capital Medical University, Beijing, China
- McLean Hospital, Belmont, MA
- Mount Sinai School of Medicine and The Mount Sinai Hospital, New York, NY
- The Medical College of Wisconsin, Inc. and Froedtert Memorial Lutheran Hospital, Inc., Milwaukee, WI
- Veterans Health Administration Central Office Human Research Protections Program, Washington, DC
"We are pleased to accredit our first human research protection program at the Beijing YouAn Hospital, Capital Medical University. With China's rapid expansion into clinical trial research we are confident that Beijing YouAn Hospital, Capital Medical University will lead the way for other Chinese institutions to put human safety and wellbeing first by becoming accredited." said Marjorie A. Speers, Ph.D., President and CEO, AAHRPP. Also among first are McLean Hospital and the Veterans Health Administration Central Office Human Research Protections Program, a federal central IRB that reviews multisite studies funded by VA and conducted at local VA facilities. Through the rigorous accreditation process, organizations must demonstrate that they have built extensive safeguards into every level of their research operation and that they adhere to the highest standards for research. The accreditation process typically results in system-wide improvements that enhance protections for research participants and promote high-quality research. Accreditation is available to organizations world-wide that conduct biomedical, behavioral or social sciences research involving human participants.Decisions on accreditation are announced quarterly, and accreditation is valid for three years.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025